If disease recurrence appeared after transplantation or ETO fusion gene level reaches positive or 10-6 levels in more than a logarithmic, we will infuse all the rest of the donor peripheral blood stem cell infusion and all patients show no symptom of GVHD or that of other complications. This evidence concerns the gene RUNX1T1 and graft versus host disease.